These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26234590)

  • 21. Managing Opioid Withdrawal in the Emergency Department With Buprenorphine.
    Herring AA; Perrone J; Nelson LS
    Ann Emerg Med; 2019 May; 73(5):481-487. PubMed ID: 30616926
    [No Abstract]   [Full Text] [Related]  

  • 22. Heroin detoxification.
    Favrat B; Besson J
    JAMA; 2006 Feb; 295(8):885; author reply 886. PubMed ID: 16493096
    [No Abstract]   [Full Text] [Related]  

  • 23. Heroin detoxification.
    Miller MM
    JAMA; 2006 Feb; 295(8):885-6; author reply 886. PubMed ID: 16493095
    [No Abstract]   [Full Text] [Related]  

  • 24. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.
    Ling W; Amass L; Shoptaw S; Annon JJ; Hillhouse M; Babcock D; Brigham G; Harrer J; Reid M; Muir J; Buchan B; Orr D; Woody G; Krejci J; Ziedonis D;
    Addiction; 2005 Aug; 100(8):1090-100. PubMed ID: 16042639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine-naloxone.
    Hu T; Nijmeh L; Pyle A
    CMAJ; 2018 Nov; 190(47):E1389. PubMed ID: 30478217
    [No Abstract]   [Full Text] [Related]  

  • 26. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
    Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
    Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA approves nonopioid medication for managing opioid withdrawal.
    Traynor K
    Am J Health Syst Pharm; 2018 Jul; 75(13):927. PubMed ID: 29941528
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine in the treatment of opioid dependence.
    Davids E; Gastpar M
    Eur Neuropsychopharmacol; 2004 May; 14(3):209-16. PubMed ID: 15056480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings.
    Sinha R; Kimmerling A; Doebrick C; Kosten TR
    Psychopharmacology (Berl); 2007 Mar; 190(4):569-74. PubMed ID: 17136399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drug buprenorphine can treat patients addicted to heroin or prescription pain medications.
    Clark HW
    W V Med J; 2003; 99(1):42. PubMed ID: 12762216
    [No Abstract]   [Full Text] [Related]  

  • 35. [A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice].
    Sofronov AG; Kuz'min AV; Pchelintsev MV; Belogurov SB
    Anesteziol Reanimatol; 1994; (4):13-5. PubMed ID: 7802310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tramadol dependence: treatment with buprenorphine/naloxone.
    Ritvo JI; Koonce R; Thurstone CC; Causey HL
    Am J Addict; 2007; 16(1):67-8. PubMed ID: 17364425
    [No Abstract]   [Full Text] [Related]  

  • 37. Opioid dependence.
    Benich JJ
    Prim Care; 2011 Mar; 38(1):59-70. PubMed ID: 21356421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine Induction: Just a Piece of the Puzzle.
    Vogel M; Dürsteler KM; Dürsteler KM
    J Addict Med; 2023 Jul-Aug 01; 17(4):494-495. PubMed ID: 37579122
    [No Abstract]   [Full Text] [Related]  

  • 39. Buprenorphine: a new treatment for opioid addiction.
    Harv Ment Health Lett; 2001 Feb; 17(8):6-7. PubMed ID: 11175458
    [No Abstract]   [Full Text] [Related]  

  • 40. What is important in drug misuse treatment?
    Seivewright NA; Greenwood J
    Lancet; 1996 Feb; 347(8998):373-6. PubMed ID: 8598706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.